6-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid

Catalog No.: 
ACTRNX381
CAS No.: 
1000340-27-1
Molecular Formula: 
C9H8N2O2
Molecular Weight: 
176.18
6-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$80.00In stockIn stock
250mg95%$135.00In stockIn stock
1g95%$361.00In stockIn stock
5g95%$1751.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
IUPAC Name6-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
MDL No.MFCD09880115
Molecular FormulaC9H8N2O2
Molecular Weight176.18
SMILESO=C(C1=CNC2=NC(C)=CC=C21)O
InChI KeyQDLZITJKHXRFDU-UHFFFAOYSA-N
Synonym1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 6-methyl-;6-METHYL-7-AZAINDOLE-3-CARBOXYLIC ACID;6-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid;2-(6-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)ACETIC ACID
CAS No.1000340-27-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTRNX381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRNX381 route product structure diagram
    ACTRNX3811000340-27-1In Stock
Inquiry

2. ACTRNX381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRNX381 route product structure diagram
    ACTRNX3811000340-27-1In Stock
Inquiry

3. ACTRNX381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTRNX381 route product structure diagram
    ACTRNX3811000340-27-1In Stock
Inquiry

Comments (0)